$3.03 Billion is the total value of BRIDGER MANAGEMENT, LLC's 38 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 58.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $123,524,000 | +14.9% | 1,881,837 | -1.2% | 4.08% | -44.3% |
| POST | Sell | POST HLDGS INC | $85,872,000 | +0.3% | 1,391,772 | -4.0% | 2.84% | -51.4% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $71,648,000 | -2.5% | 609,046 | -3.9% | 2.37% | -52.8% |
| AET | Sell | AETNA INC NEW | $60,769,000 | -22.7% | 562,051 | -21.8% | 2.01% | -62.5% |
| VRSN | Sell | VERISIGN INC | $35,961,000 | -17.2% | 411,637 | -33.1% | 1.19% | -59.9% |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $28,994,000 | -47.2% | 370,720 | -41.8% | 0.96% | -74.4% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $18,668,000 | -19.2% | 706,848 | -3.8% | 0.62% | -60.8% |
| NVLS | Exit | NIVALIS THERAPEUTICS INC | $0 | – | -33,159 | -100.0% | -0.03% | – |
| MPC | Exit | MARATHON PETE CORP | $0 | – | -110,890 | -100.0% | -0.35% | – |
| ELGX | Exit | ENDOLOGIX INC | $0 | – | -675,421 | -100.0% | -0.56% | – |
| BCC | Exit | BOISE CASCADE CO DEL | $0 | – | -904,341 | -100.0% | -1.56% | – |
| PFSI | Exit | PENNYMAC FINL SVCS INCcl a | $0 | – | -1,776,073 | -100.0% | -1.94% | – |
| AGO | Exit | ASSURED GUARANTY LTD | $0 | – | -1,437,876 | -100.0% | -2.45% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -2,083,679 | -100.0% | -2.99% | – |
| KYTH | Exit | KYTHERA BIOPHARMACEUTICALS I | $0 | – | -641,036 | -100.0% | -3.28% | – |
| PODD | Exit | INSULET CORP | $0 | – | -2,165,850 | -100.0% | -3.83% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -729,813 | -100.0% | -3.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.